CELZ insider trading
NasdaqCM HealthcareCREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.: insider trade history from SEC Form 4 filings.
About CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pain; Alova, which is in IND-enabling phase, to treat infertility as a result of premature ovarian failure; iPSCelz, which is in pre-clinical stage, a platform to make cell type in the body; StemSpine, a regenerative stem cell procedure to treat degenerative disc disease; OvaStem, a stem cell therapy for premature ovarian failure; CaverStem for erectile dysfunction treatment; and FemCelz for female sexual function treatment. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Company website: www.creativemedicaltechnology.com
CELZ insider activity at a glance
FilingIQ tracks 67 insider transactions for CELZ in filings since Nov 14, 2016. The most recent transaction is dated Sep 24, 2026.
Across the full history, 23 open-market purchases
and 23 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on CELZ insider trades is 58.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest CELZ Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for CELZ?
- FilingIQ tracks 67 Form 4 insider transactions for CELZ (CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.), covering filings from Nov 14, 2016 onwards. 1 of those are dated within the last 90 days.
- Are CELZ insiders net buyers or net sellers?
- Across the full Form 4 history for CELZ, 23 transactions (34%) were open-market purchases and 23 (34%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CELZ insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is CELZ in?
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $6.43M.
Methodology & sources
Every CELZ insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.